Karyopharm Therapeutics Inc. Assets, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $106.38M.
- 2026-03-31: Assets, Current $126.33M.
- 2025-12-31: Assets, Current $103.15M.
- 2025-09-30: Assets, Current $89.75M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $106.38M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $126.33M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $103.15M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $89.75M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $97.87M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $120.24M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $156.46M 10-K · filed 2026-02-13 | $156.49M 10-K · filed 2025-02-19 |
| 2024-09-30 | $184.75M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $208.54M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $198.37M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $233.92M 10-K · filed 2025-02-19 | |
| 2023-09-30 | $263.22M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $291.38M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $318.54M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $350.16M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $222.68M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $242.45M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $276.53M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $275.61M 10-K · filed 2023-02-17 | |
| 2021-09-30 | $241.58M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $273.50M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $255.51M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $276.53M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $285.45M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $317.84M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $370.92M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $278.57M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $280.87M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $222.83M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $271.44M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $334.61M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $211.56M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $244.56M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $133.31M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $148.42M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $121.68M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $145.72M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $112.23M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $131.64M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $130.25M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $124.20M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $138.14M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $177.60M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $198.34M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $225.25M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $249.32M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $207.75M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $231.35M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $135.28M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $147.57M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $157.96M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $53.59M 10-Q/A · filed 2013-12-23 | |
| 2012-12-31 | $954.00K 10-K · filed 2014-03-21 |